Apar Kishor Ganti, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Jazz Pharmaceuticals
    Topic:
    SCLC RWE
    Date added:
    12/12/2023
    Date updated:
    12/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astra Zeneca
    Topic:
    Metastatic NSCLC
    Date added:
    12/12/2023
    Date updated:
    12/12/2023
    Relationship end date:
    12/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Cardinal Health
    Topic:
    Meeting highlights lung cancer
    Date added:
    12/12/2023
    Date updated:
    12/12/2023
    Relationship end date:
    10/28/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Flagship Biosciences
    Topic:
    HNSCC
    Date added:
    12/12/2023
    Date updated:
    12/12/2023
    Relationship end date:
    12/31/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Regeneron Pharmaceuticals
    Topic:
    NSCLC
    Date added:
    12/12/2023
    Date updated:
    12/12/2023
    Relationship end date:
    12/31/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Mirati Therapeutics
    Topic:
    KRAS G12C
    Date added:
    12/12/2023
    Date updated:
    12/12/2023
    Relationship end date:
    12/31/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Beigene Ltd
    Topic:
    NSCLC
    Date added:
    12/12/2023
    Date updated:
    12/12/2023
    Relationship end date:
    12/31/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sanofi Genzyme
    Topic:
    NSCLC
    Date added:
    12/12/2023
    Date updated:
    12/12/2023
    Relationship end date:
    12/31/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Takeda
    Topic:
    IGF1-R
    Date added:
    12/12/2023
    Date updated:
    12/12/2023
    Relationship end date:
    12/31/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    YmAbs Therapeutics
    Topic:
    DSMC Chair
    Date added:
    12/12/2023
    Date updated:
    12/12/2023
    Relationship end date:
    12/31/2022
Return to Iowa Hematology Oncology Conference: Emphasis on Precision-Guided Management